Provided by Tiger Trade Technology Pte. Ltd.

Dyne Therapeutics, Inc.

15.62
-0.5700-3.52%
Post-market: 15.10-0.5200-3.33%19:59 EST
Volume:1.93M
Turnover:29.97M
Market Cap:2.53B
PE:-4.31
High:16.01
Open:15.72
Low:15.10
Close:16.19
52wk High:25.00
52wk Low:6.36
Shares:162.00M
Float Shares:152.00M
Volume Ratio:0.92
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6224
EPS(LYR):-3.3716
ROE:-60.66%
ROA:-34.32%
PB:3.66
PE(LYR):-4.63

Loading ...

Stock Track | Dyne Therapeutics Plummets 5.08% Following Oppenheimer's Price Target Cut

Stock Track
·
Nov 13, 2025

Oppenheimer Adjusts Price Target on Dyne Therapeutics to $11 From $13, Maintains Perform Rating

MT Newswires Live
·
Nov 12, 2025

Dyne Therapeutics (DYN) Gets a Hold from Oppenheimer

TIPRANKS
·
Nov 12, 2025

RBC Capital Remains a Buy on Dyne Therapeutics (DYN)

TIPRANKS
·
Nov 07, 2025

Dyne Therapeutics price target lowered to $38 from $41 at Evercore ISI

TIPRANKS
·
Nov 07, 2025

Dyne Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Nov 07, 2025

Dyne Therapeutics Inc : H.c. Wainwright Raises Target Price to $46 From $38

THOMSON REUTERS
·
Nov 06, 2025

Analysts Offer Insights on Healthcare Companies: Cencora (COR), Dyne Therapeutics (DYN) and Enhabit, Inc (EHAB)

TIPRANKS
·
Nov 06, 2025

RBC Raises Price Target on Dyne Therapeutics to $30 From $23, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Nov 06, 2025

Dyne Therapeutics Q3 net loss beats expectations

Reuters
·
Nov 06, 2025

Dyne Therapeutics Q3 EPS $(0.76) Beats $(0.85) Estimate

Benzinga
·
Nov 06, 2025

Dyne Therapeutics reports $791.9 million cash position as of September 30, 2025

Reuters
·
Nov 06, 2025

Dyne Therapeutics Q3 Basic EPS USD -0.76

THOMSON REUTERS
·
Nov 06, 2025

Dyne Therapeutics Q3 EPS USD -0.76 VS. Ibes Estimate USD -0.84

THOMSON REUTERS
·
Nov 06, 2025

Dyne Therapeutics Inc: Reaffirming Expected Cash Runway Into Q3 2027

THOMSON REUTERS
·
Nov 06, 2025

Dyne Therapeutics Inc : JP Morgan Raises Target Price to $18 From $9

THOMSON REUTERS
·
Nov 05, 2025

Dyne Therapeutics to Present at Evercore Healthcare Conference

Reuters
·
Nov 03, 2025

This biotech's stock soared as investors look for the next buyout target

Dow Jones
·
Oct 28, 2025

Small U.S. Stocks End Mixed As Dyne Therapeutics Leads, Intellia Therapeutics Lags

Dow Jones
·
Oct 28, 2025

Dyne Therapeutics Shares Rise After Novartis Reaches Deal to Buy Avidity

Dow Jones
·
Oct 28, 2025